Hirtle Callaghan & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-36,679
| Closed | -$1.52M | – | 116 |
|
|
2018
Q4 | $1.52M | Hold |
36,679
| – | – | 0.13% | 30 |
|
|
2018
Q3 | $1.53M | Hold |
36,679
| – | – | 0.14% | 30 |
|
|
2018
Q2 | $1.26M | Hold |
36,679
| – | – | 0.12% | 33 |
|
|
2018
Q1 | $1.24M | Hold |
36,679
| – | – | 0.11% | 31 |
|
|
2017
Q4 | $1.26M | Sell |
36,679
-2,007
| -5% | -$68.4K | 0.12% | 31 |
|
|
2017
Q3 | $1.31M | Buy |
38,686
+36,679
| +1,828% | +$1.18M | 0.13% | 26 |
|
|
2017
Q2 | $64K | Sell |
2,007
-499
| -20% | -$15.7K | 0.01% | 51 |
|
|
2017
Q1 | $82K | Hold |
2,506
| – | – | 0.01% | 47 |
|
|
2016
Q4 | $78K | Sell |
2,506
-56,599
| -96% | -$1.73M | 0.01% | 50 |
|
|
2016
Q3 | $1.9M | Buy |
59,105
+17,541
| +42% | +$587K | 0.39% | 20 |
|
|
2016
Q2 | $1.39M | Sell |
41,564
-825
| -2% | -$26.3K | 0.26% | 23 |
|
|
2016
Q1 | $1.19M | Buy |
42,389
+35,435
| +510% | +$1.01M | 0.22% | 23 |
|
|
2015
Q4 | $211K | Sell |
6,954
-11,183
| -62% | -$352K | 0.05% | 52 |
|
|
2015
Q3 | $540K | Hold |
18,137
| – | – | 0.09% | 18 |
|
|
2015
Q2 | $577K | Buy |
+18,137
| New | +$591K | 0.19% | 17 |
|
|
2015
Q1 | – | Sell |
-86,548
| Closed | -$2.56M | – | 274 |
|
|
2014
Q4 | $2.56M | Buy |
86,548
+268
| +0.3% | +$7.68K | 0.59% | 33 |
|
|
2014
Q3 | $2.42M | Buy |
86,280
+17
| +0% | +$477 | 0.4% | 41 |
|
|
2014
Q2 | $2.43M | Sell |
86,263
-17
| -0% | -$485 | 0.34% | 45 |
|
|
2014
Q1 | $2.63M | Buy |
86,280
+137
| +0.2% | +$4.08K | 0.43% | 36 |
|
|
2013
Q4 | $2.5M | Buy |
86,143
+997
| +1% | +$29K | 0.34% | 40 |
|
|
2013
Q3 | $2.32M | Buy |
85,146
+71,796
| +538% | +$1.95M | 0.37% | 45 |
|
|
2013
Q2 | $355K | Buy |
+13,350
| New | +$369K | 4.11% | 8 |
|
Other funds holding PFE
